Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body's defense systems, according to a study led by investigators at Weill Cornell ...

Squeeze a cell once and it barely flinches. Squeeze it again and again in short bursts, and something changes: a protein ...

New ALS drug enters human trials after reversing a key protein in animals and could change the future of treatment.

Findings identify strategy for boosting anticancer immunity and potentially a new tool for delivering genetic payloads to ...

Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...

The company behind the dire wolf comeback hopes to restore Africa's bluebuck, once hunted to extinction by colonialists.

For decades, depression has been explained to patients as a “chemical imbalance” in the brain, a vague phrase that never ...

Acurastem has received $7.5 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance AS-241, its lead clinical candidate for amyotrophic lateral sclerosis (ALS) and ...

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body's defense systems ...

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body's ...